June 16, 2020
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Brickell Biotech, Inc.
Amendment No. 1 to Registration Statement on Form S-1
File Number 333-238298
Ladies and Gentlemen:
Brickell Biotech, Inc. (the “Company”) hereby requests that the effectiveness of the above-referenced registration statement on Form S-1/A be accelerated so that it will become effective at 4:00 p.m. Eastern time on June 17, 2020, or as soon thereafter as practicable.
Please telephone the undersigned (305-582-4657) or Jonathan R. Zimmerman of Faegre Drinker Biddle & Reath LLP (612-766-8419) if you have any questions with respect to the foregoing.
| | | | | | | | | | | |
| | | |
| | | |
| | Very truly yours, | | |
| | | |
| | BRICKELL BIOTECH, INC.
| | |
| | By: | /s/ Andrew Sklawer | |
| | | Name: Andrew Sklawer | |
| | | Title: Chief Operating Officer | |
